T. Rowe Price Investment Management
MRVI icon

T. Rowe Price Investment Management’s Maravai LifeSciences MRVI Stock Holding History

T. Rowe Price Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000,000
Closed -$2.83M – 783
2026
Q1 		$2.83M Sell
1,000,000
-5,336,680
-84% -$18.1M ﹤0.01% 588
2025
Q4 		$20.6M Buy
6,336,680
+178,445
+3% +$601K 0.01% 488
2025
Q3 		$17.7M Buy
6,158,235
+3,514,539
+133% +$8.97M 0.01% 513
2025
Q2 		$6.37M Buy
+2,643,696
New +$5.56M ﹤0.01% 573

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

T. Rowe Price Investment Management's MRVI Position: Q2 2026 in Review

T. Rowe Price Investment Management sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 1,000,000 shares — an estimated $2.83M sold.

T. Rowe Price Investment Management first reported a position in MRVI in Q2 2025 and held it in 4 quarters. The position peaked at $20.6M in Q4 2025. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • T. Rowe Price Investment Management reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,000,000 Maravai LifeSciences shares in Q2 2026, an estimated $2.83M.
  • T. Rowe Price Investment Management first reported a position in Maravai LifeSciences in Q2 2025 and held it in 4 quarters.
  • T. Rowe Price Investment Management's Maravai LifeSciences position peaked at $20.6M in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.